Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Regeneron/Sanofi’s PSCK9 Inhibitor Might Need Two-Week Dosing Schedule

May 30 2012

Related Content

Branded Life After <em>Lipitor</em>: Pharma Targets Unmet Needs In Dyslipidemia

Apr 23 2012

Regeneron/Sanofi’s Long-Term Alliances Begin Bearing Fruit

Apr 02 2012

Related Companies

Regeneron Pharmaceuticals, Inc.

Sanofi

AstraZeneca PLC

Pfizer Inc.

Merck & Co., Inc.

Amgen, Inc.

Alnylam Pharmaceuticals Inc.

Additional Topics

Clinical Trials Research & Development BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window